Literature DB >> 23274781

Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease.

J W Hwang1, H M Yang, H Lee, H K Lee, Y T Jeon, J E Kim, Y J Lim, H P Park.   

Abstract

BACKGROUND: Symptomatic cerebral hyperperfusion (SCH) is a potential complication after superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis in patients with moyamoya disease. This retrospective study was designed to determine factors associated with SCH after STA-MCA anastomosis in adult moyamoya patients.
METHODS: Eighty-two adult moyamoya patients undergoing STA-MCA anastomosis between July 2005 and December 2010 were enrolled. Laboratory data such as haemoglobin and white blood cell (WBC) count, preoperative (patient characteristic data, initial clinical manifestation, the angiographic staging), intraoperative (surgical time, the operative side, anaesthetic technique, fluid balance, arterial pressure, arterial partial pressure of carbon dioxide, the lowest haematocrit, and intraoperative transfusion), and postoperative (arterial pressure, Acute Physiology and Chronic Health Evaluation II score) data were collected and used as predictable factors for postoperative SCH, in which a focal intense increase in cerebral blood flow at the anastomosis site was shown in postoperative single-photon emission computed tomography.
RESULTS: Among 82 patients with 99 surgeries, 39 patients (47 sides, 47%) suffered from transient neurological deterioration due to SCH from 1 to 9 days after operation (median: 2 days), which was sustained for 1-14 days (median: 7 days). The operation on the dominant hemisphere [odds ratio (OR), 5.09; 95% confidence interval (CI), 2.07-12.54, P<0.001] was an independent risk factor for SCH. Also, WBC count on postoperative day 1 was significantly correlated with SCH (OR 1.19; 95%CI, 1.02-1.38, P=0.029).
CONCLUSIONS: The operation on the dominant hemisphere and increased postoperative WBC count may be associated with SCH after STA-MCA anastomosis in adult-onset moyamoya patients.

Entities:  

Mesh:

Year:  2012        PMID: 23274781     DOI: 10.1093/bja/aes470

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients-case-control study.

Authors:  Masahito Katsuki; Miki Fujimura; Ryosuke Tashiro; Yasutake Tomata; Taketo Nishizawa; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2020-09-24       Impact factor: 3.042

Review 2.  Significance of Cerebral Blood Flow Analysis in the Acute Stage after Revascularization Surgery for Moyamoya Disease.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-09-15       Impact factor: 1.742

Review 3.  Progress on Complications of Direct Bypass for Moyamoya Disease.

Authors:  Jinlu Yu; Lei Shi; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

4.  Intraoperative dexmedetomidine and postoperative cerebral hyperperfusion syndrome in patients who underwent superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: A retrospective observational study.

Authors:  Hyungseok Seo; Ho-Geol Ryu; Je Do Son; Jeong-Soo Kim; Eun Jin Ha; Jeong-Eun Kim; Hee-Pyoung Park
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

5.  Effects of end-tidal carbon dioxide levels in patients undergoing direct revascularization for Moyamoya disease and risk factors associated with postoperative complications.

Authors:  Tingting Song; Xiancun Liu; Rui Han; Lihua Huang; Jingjing Zhang; Haiyang Xu
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

6.  Risk factors for postoperative ischemic complications in pediatric moyamoya disease.

Authors:  Xiaofeng Deng; Peicong Ge; Rong Wang; Dong Zhang; Jizong Zhao; Yan Zhang
Journal:  BMC Neurol       Date:  2021-06-22       Impact factor: 2.474

7.  Long-Lasting Symptomatic Cerebral Hyperperfusion Syndrome following Superficial Temporal Artery-Middle Cerebral Artery Bypass in a Patient with Stenosis of Middle Cerebral Artery.

Authors:  Shinji Shimato; Toshihisa Nishizawa; Takashi Yamanouchi; Takashi Mamiya; Kojiro Ishikawa; Kyozo Kato
Journal:  Case Rep Neurol Med       Date:  2018-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.